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 Supplementary Tables 
 
 
Supplementary Table 1: Summary results from the GCAS with gene expression in adipose tissue in 
the Swedish discordant sib-pair dataset at different FDR thresholds. 
 
 
FDR Associations Transcripts
* 
Probes
* 
Ensembl Genes
* 
10% 171 79 131 84 
5% 149 66 115 73 
1% 105 41 76 40 
 
* Multiple associations may be observed for the same probe with different transcripts, some of which can be 
transcribed from the same gene. P values for FDR were corrected for the observed inflation (lambda = 1.12). 
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Supplementary Table 2: Association of copy-number signal at the AMY1 and AMY2 loci, inferred 
through qPCR, in subjects with complete BMI and fat mass data in the Swedish study of sib-pairs 
discordant for BMI.  
 
 
Gene N Trait β (SE) P 
AMY1 481 BMI -0.34 (0.13) 8.08×10-3 
AMY2 478 BMI -0.02 (0.59) 0.97 
AMY1 481 Fat mass -0.69 (0.26) 8.53×10-3 
AMY2 478 Fat mass -0.11 (1.19) 0.92 
 
  
5 
 
Supplementary Table 3: Coordinates of genotyped loci in Build 37 of the human reference genome 
and the associate number of k-mer informative sites in each of these loci on chromosome 1. 
 
 
Start End SUNKs Paralog 
104085264 104131162 15298 AMY2B 
104140218 104173355 2150 AMY2A 
104186809 104209356 109 AMY1A1 
104218850 104243770 25 AMY1A2 
104278480 104307257 432 AMY1A3 
104249110 104268394 150 AMYP 
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Supplementary Table 4: Inferred copy-number frequency at AMY1 in the TwinsUK and DESIR 
samples. Estimates in TwinsUK were calculated using a random unrelated subsample. 
 
Estimated AMY1  TwinsUK DESIR 
copy-number N Frequency N Frequency 
1 0 0.000 6 0.003 
2 25 0.026 60 0.028 
3 70 0.074 168 0.079 
4 160 0.169 286 0.134 
5 186 0.196 427 0.200 
6 182 0.192 393 0.184 
7 103 0.109 229 0.107 
8 77 0.081 187 0.088 
9 56 0.059 121 0.057 
10 38 0.040 109 0.051 
11 18 0.019 54 0.025 
12 13 0.014 44 0.021 
13 13 0.014 20 0.009 
14 4 0.004 15 0.007 
15 2 0.002 10 0.005 
16 1 0.001 7 0.003 
17 1 0.001 1 <0.001 
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Supplementary Table 5: Allele frequencies at AMY1 estimated copy-number in the TwinsUK and 
DESIR samples. Estimates in TwinsUK were calculated using a random unrelated subsample. Allele 
frequencies were estimated through the EM algorithm implemented in CoNVEM
26
. 
(http://apps.biocompute.org.uk/convem/). 
 
 
AMY1 allele Frequency TwinsUK Frequency DESIR 
0 0.000 0.014 
1 0.161 0.133 
2 0.230 0.239 
3 0.359 0.339 
4 0.096 0.097 
5 0.057 0.075 
6 0.041 0.025 
7 0.038 0.049 
8 0.004 0.007 
9 0.000 0.015 
10 0.014 0.002 
11 0.000 0.001 
12 0.000 0.003 
13 0.000 <0.001 
 
  
8 
 
Supplementary Table 6: Average BMI per inferred copy-number state in the TwinsUK cohort. 
Observations with less than 30 subjects are not reported.  
 
 
Estimated AMY1 
copy-number 
N BMI* SE 
2 44 26.73 0.87 
3 124 26.72 0.41 
4 210 26.32 0.34 
5 310 26.50 0.28 
6 296 26.05 0.30 
7 142 25.02 0.33 
8 121 25.78 0.34 
9 84 25.16 0.43 
10 60 25.28 0.59 
11 37 25.02 0.60 
 
 
  
9 
 
Supplementary Table 7: Average estimated copy-number at the AMY1 gene in the TwinsUK cohort 
per BMI category, presented according to the WHO International Classification of adult underweight, 
overweight and obesity. 
 
Classification N  Mean AMY1  
copy-number 
SE 
Underweight 14 7.07 0.79 
Normal range 697 6.19 0.09 
Pre obese 517 6.17 0.11 
Obese class I 169 5.85 0.19 
Obese class II 64 5.41 0.29 
Obese class III 18 5.11 0.31 
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Supplementary Table 8. Average BMI per estimated copy-number state in the DESIR cohort. 
Observations with less than 30 subjects are not reported.  
 
 
Estimated AMY1  
copy-number 
N BMI* SE 
2 60 25.06 0.54 
3 168 25.06 0.24 
4 286 24.92 0.21 
5 427 24.85 0.17 
6 393 24.32 0.17 
7 229 24.54 0.21 
8 187 24.50 0.26 
9 121 24.34 0.32 
10 109 23.98 0.31 
11 54 23.73 0.41 
12 44 23.21 0.38 
 
*BMI is the averaged value among the four time points.  
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Supplementary Table 9. Average estimated copy-number at the AMY1 gene in the DESIR cohort per 
BMI category, presented according to the WHO International Classification of adult underweight, 
overweight and obesity. 
 
 
Classification N  Mean AMY1  
copy-number 
SE 
Underweight 28 6.89 0.51 
Normal range 1239 6.49 0.08 
Pre obese 733 6.04 0.09 
Obese class I 115 5.63 0.21 
Obese class II 20 5.00 0.48 
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Supplementary Table 10: Association of copy-number estimates in the extreme deciles of the AMY1 
copy-number distribution, measured by qPCR, with obesity risk in the AOB case control study and the 
case-control samples derived from the TwinsUK and DESIR population studies. Meta-analysis was 
assessed with the software METAL. 
 
 Cases Controls     
Sample N Age* N Age* β (SE) P OR (95%CI)  
TwinsUK 53 52 (48-60) 137 51 (42-59) -2.14 (1.02) 3.60E-2 8.49 (1.15-62.80)  
DESIR 26 51 (44-60) 301 46 (38-53) -1.82 (0.51) 4.07E-4 6.18 (2.25-16.95)  
AOB 40 34 (29-40) 76 36 (33-39) -2.22 (0.51) 1.33E-5 9.25 (3.40-24.19)  
         
 N  N  β (SE) P OR (95%CI) Het P** 
Meta-analysis 119  514  -2.04 (0.34) 2.52E-9 7.67 (3.92-14.99) 0.85 
 
*median (1st, 3rd quartiles) ** Heterogeneity P value 
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Supplementary Table 11: Association results for the estimation of variance of obesity explained 
by estimated AMY1 copy-number. The effect of AMY1 on obesity was first assessed by comparing 
high (≥8) versus medium (≥5 and ≤7) and low (≤4) copy-number carriers in AOB and the TwinsUK- 
and DESIR-derived (by selecting cases and controls from the respective population sample) case-
control studies. Meta-analysis was performed using the software METAL which performs an inverse-
variance method of meta-analysis with fixed effects, by combining effect sizes and weighting them by 
their standard errors. The presented combined effect sizes were then used to calculate the proportion of 
variance of obesity explained by copy-number variation at the salivary amylase gene using the method 
of So et al
16
. 
 
Sample AMY1 copy-
number 
N β (SE) P   
AOB ≤4 147 - -   
 ≥5 ≤7 281 0.58(0.23) 1.12E-02   
 ≥8 135 0.80(0.26) 2.21E-03   
       
TUK ≤4 246 - -   
 ≥5 ≤7 498 0.75 (0.45) 9.30E-02   
 ≥8 218 2.40 (0.89) 7.00E-03   
       
DESIR ≤4 325 - -   
 ≥5 ≤7 686 0.51 (0.25) 3.93E-02   
 ≥8 393 0.91 (0.27) 7.68E-04   
       
Meta 
analysis 
AMY1 copy-
number 
N β (SE) P Het P* OR (95% CI) 
 ≤4 718 - -  1 
 ≥5 ≤7 1465 0.57 (0.16) 2.68E-04 0.90 1.78 (1.30-2.42) 
 ≥8 746 0.92 (0.18) 5.85E-07 0.23 2.51 (1.75-3.59) 
 
Het P** =heterogeneity P value 
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Supplementary Table 12: Summary of salivary amylase protein levels in serum categorised by copy-
numbers of the AMY1 gene estimated by qPCR in the ABOS sample. Only copy-numbers present in 
>10 subjects are reported. 
 
 Gene Copy-number N Mean salivary amylase (IU/L) SE 
 AMY1  2 16 4.06 0.98 
  3 53 12.42 0.81 
  4 51 15.41 1.06 
  5 139 20.73 0.74 
  6 65 23.00 1.11 
  7 65 23.86 1.21 
  8 39 27.33 1.60 
  9 17 27.65 2.72 
 AMY2 1 56 18.68 1.29 
  2 347 20.31 0.55 
  3 56 24.00 1.37 
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Supplementary Table 13: LD Analysis in the AMY1 Region in the TwinsUK Sample. 
  
SNP-SNP 
SNP-AMY1 CN 
(please see text for 1,2,3 definitions) 
SNP 
Position 
(bp) 
r2 
(Haplotype Frequency) 
r2 
(Corr) AMY1(1) AMY1(2) AMY1(3) 
rs10785777 103916755 - - 0.01 0.02 0.02 
rs6696797 104017778 0.96 0.96 0.02 0.02 0.02 
rs7524694 104019631 0.07 0.07 0.02 0.01 0.01 
rs12125927 104043185 0.01 0.01 0.00 0.00 0.00 
rs2050592 104103057 0.01 0.01 0.01 0.02 0.02 
rs10159229 104109958 0.06 0.06 0.02 0.02 0.02 
rs12085609 104122556 1.00 1.00 0.02 0.02 0.02 
rs4847151 104123662 1.00 1.00 0.02 0.02 0.02 
rs6661612 104128618 1.00 1.00 0.02 0.02 0.02 
rs1999478 104311712 0.13 0.13 0.02 0.01 0.01 
rs504877 104315497 0.15 0.14 0.00 0.00 0.00 
rs7515323 104318414 1.00 1.00 0.00 0.00 0.00 
rs550437 104319480 1.00 1.00 0.00 0.00 0.00 
rs11185098 104321349 0.20 0.23 0.05 0.02 0.04 
rs1930213 104324720 0.20 0.23 0.00 0.00 0.00 
rs1930212 104324819 0.14 0.12 0.03 0.03 0.03 
rs1566154 104329877 0.05 0.05 0.02 0.02 0.01 
rs1930211 104342898 0.38 0.32 0.00 0.00 0.00 
rs10881476 104350777 0.99 0.98 0.00 0.01 0.00 
rs9628996 104350971 1.00 1.00 0.00 0.01 0.00 
rs12136807 104401489 0.09 0.10 0.00 0.00 0.00 
rs1579026 104405855 1.00 1.00 0.00 0.00 0.00 
rs1930192 104408821 1.00 1.00 0.00 0.00 0.00 
rs1930194 104409499 1.00 1.00 0.00 0.00 0.00 
s1930195 104414641 1.00 1.00 0.00 0.00 0.00 
rs1999480 104419830 1.00 1.00 0.00 0.00 0.00 
rs1182598 104429480 1.00 1.00 0.00 0.00 0.00 
rs12143917 104433984 0.75 0.74 0.00 0.00 0.00 
rs1182591 104435039 0.75 0.75 0.00 0.00 0.00 
rs7531107 104436329 0.92 0.92 0.00 0.00 0.00 
rs1182589 104436874 0.34 0.33 0.01 0.01 0.01 
rs1182587 104437902 0.33 0.33 0.00 0.00 0.00 
rs1930208 104445316 0.26 0.29 0.01 0.00 0.01 
rs1111700 104454507 0.23 0.28 0.00 0.00 0.00 
rs1475190 104470622 0.57 0.57 0.00 0.00 0.00 
rs551284 104484407 0.89 0.91 0.00 0.00 0.00 
rs619879 104487148 1.00 1.00 0.00 0.00 0.00 
rs1330388 104492281 0.43 0.41 0.00 0.00 0.00 
rs11185345 104502333 0.60 0.62 0.00 0.01 0.01 
rs6694128 104505231 0.88 0.89 0.00 0.01 0.00 
rs2208963 104529736 0.74 0.73 0.00 0.01 0.00 
rs519975 104536508 0.87 0.87 0.00 0.01 0.01 
rs508464 104540638 0.88 0.88 0.00 0.01 0.00 
rs750236 104544187 0.96 0.97 0.00 0.00 0.00 
rs750237 104544302 1.00 1.00 0.00 0.00 0.00 
rs11185353 104545275 0.97 0.98 0.00 0.01 0.01 
rs7546635 104545772 1.00 1.00 0.00 0.01 0.00 
rs2181446 104546362 1.00 1.00 0.00 0.01 0.00 
rs10881526 104546516 0.96 0.98 0.00 0.00 0.00 
rs1330408 104546820 0.96 0.97 0.00 0.01 0.01 
rs1330407 104546881 1.00 1.00 0.00 0.01 0.01 
rs11185354 104547208 1.00 1.00 0.00 0.01 0.01 
rs4141899 104547617 0.97 0.98 0.00 0.01 0.00 
rs11185362 104561488 0.88 0.87 0.00 0.01 0.01 
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Supplementary Table 14: Association between BMI and eleven SNPs at the FTO gene included in the 
haploblock on chromosome 16q12.2 within 53,797kb-53,850kb in the TwinsUK sample. For 
comparison, association with estimated AMY1 copy-number is reported for the same subset of subjects 
using a dichotomous variable for estimated AMY1 copy-numbers <6 and ≥6. 
 
   FTO   AMY1 
SNP Position Subjects Beta SE P Beta SE P 
rs1075440 53790906 1388 -0.41 0.19 2.95E-02 -0.86 0.25 5.52E-04 
rs1558902 53803574 1324 0.39 0.19 3.47E-02 -0.89 0.25 4.14E-04 
rs17817449 53813367 1368 0.42 0.18 2.32E-02 -0.85 0.25 6.76E-04 
rs8043757 53813450 1368 0.42 0.18 2.32E-02 -0.85 0.25 6.76E-04 
rs8050136 53816275 1388 0.42 0.18 2.12E-02 -0.86 0.25 5.52E-04 
rs8051591 53816752 1382 0.44 0.18 1.62E-02 -0.86 0.25 5.76E-04 
rs9935401 53816838 1382 0.44 0.18 1.62E-02 -0.86 0.25 5.76E-04 
rs3751812 53818460 1388 0.45 0.18 1.44E-02 -0.86 0.25 5.52E-04 
rs7190492 53828752 1388 -0.07 0.18 7.23E-01 -0.86 0.25 5.52E-04 
rs8044769 53839135 1388 -0.27 0.18 1.31E-01 -0.86 0.25 5.52E-04 
rs1421090 53850170 1388 -0.03 0.21 8.86E-01 -0.86 0.25 5.52E-04 
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Supplementary Table 15: Association between BMI and 104 SNPs of the FTO gene included in the 
haploblock on chromosome 16q12.2 within 53,797kb-53,850kb in the DESIR sample. For comparison, 
association with estimated AMY1 copy-number is reported for the same subset of subjects using a 
dichotomous variable for AMY1 estimated copy-numbers <6 and ≥6. 
 
   FTO   AMY1 
SNP Position Subjects Beta SE P Beta SE P 
rs60386982 53797452 2126 -0.02 0.16 8.98E-01 -0.64 0.14 5.94E-06 
rs6499643 53797518 2125 -0.02 0.13 8.74E-01 -0.64 0.14 6.87E-06 
rs4784323 53797565 2125 -0.23 0.11 3.82E-02 -0.64 0.14 6.55E-06 
rs7206790 53797908 2128 0.18 0.10 7.70E-02 -0.65 0.14 5.46E-06 
rs8047395 53798523 2124 -0.16 0.10 1.07E-01 -0.64 0.14 7.81E-06 
rs8047587 53798622 2118 0.24 0.10 1.84E-02 -0.64 0.14 7.43E-06 
rs9937053 53799507 2123 0.25 0.10 1.41E-02 -0.65 0.14 5.53E-06 
rs9937354 53799847 2122 0.25 0.10 1.29E-02 -0.65 0.14 5.12E-06 
rs9928094 53799905 2122 0.25 0.10 1.38E-02 -0.64 0.14 6.33E-06 
rs9930333 53799977 2107 0.25 0.10 1.32E-02 -0.64 0.14 8.42E-06 
rs9930397 53799985 2123 0.24 0.10 1.62E-02 -0.65 0.14 4.93E-06 
rs9939973 53800568 2124 0.24 0.10 1.58E-02 -0.64 0.14 6.74E-06 
rs9940646 53800629 2123 0.25 0.10 1.42E-02 -0.65 0.14 5.50E-06 
rs9940128 53800754 2124 0.24 0.10 1.97E-02 -0.64 0.14 7.38E-06 
rs1421085 53800954 2128 0.24 0.10 1.89E-02 -0.64 0.14 6.55E-06 
rs9923147 53801549 2129 0.25 0.10 1.23E-02 -0.65 0.14 5.75E-06 
rs9923544 53801985 2121 0.25 0.10 1.23E-02 -0.62 0.14 1.14E-05 
rs11642015 53802494 2123 0.24 0.10 1.98E-02 -0.64 0.14 6.89E-06 
rs8055197 53803156 2127 -0.14 0.10 1.44E-01 -0.65 0.14 5.33E-06 
rs1558901 53803187 2124 0.24 0.10 1.76E-02 -0.65 0.14 5.70E-06 
rs62048402 53803223 2127 0.24 0.10 2.02E-02 -0.64 0.14 6.15E-06 
rs1558902 53803574 2115 0.25 0.10 1.56E-02 -0.65 0.14 5.76E-06 
rs1861866 53804340 2127 -0.14 0.10 1.47E-01 -0.65 0.14 5.43E-06 
rs10852521 53804965 2124 -0.14 0.10 1.50E-01 -0.64 0.14 6.99E-06 
rs11075985 53805207 2122 0.24 0.10 1.67E-02 -0.64 0.14 6.87E-06 
rs11075986 53805344 2125 -0.34 0.18 5.49E-02 -0.63 0.14 8.18E-06 
rs2058908 53806145 2129 -0.21 0.12 7.57E-02 -0.64 0.14 7.31E-06 
rs9922047 53806280 2120 -0.15 0.10 1.43E-01 -0.64 0.14 7.53E-06 
rs56094641 53806453 2125 0.24 0.10 1.56E-02 -0.65 0.14 5.71E-06 
rs17817288 53807764 2127 -0.13 0.10 2.05E-01 -0.64 0.14 7.61E-06 
rs53808258 53808258 2126 -0.14 0.10 1.72E-01 -0.63 0.14 8.53E-06 
rs55872725 53809123 2121 0.23 0.10 2.25E-02 -0.63 0.14 9.27E-06 
rs1121980 53809247 2126 0.24 0.10 1.56E-02 -0.64 0.14 6.58E-06 
rs73612011 53809861 2130 -0.34 0.20 8.45E-02 -0.64 0.14 6.56E-06 
rs7187250 53810546 2125 0.21 0.10 3.93E-02 -0.65 0.14 5.90E-06 
rs7193144 53810686 2109 0.20 0.10 5.29E-02 -0.61 0.14 2.09E-05 
rs8063057 53812433 2129 0.23 0.10 2.37E-02 -0.64 0.14 6.26E-06 
rs16945088 53812524 2130 -0.24 0.18 1.88E-01 -0.64 0.14 6.56E-06 
rs8057044 53812614 2127 0.13 0.10 1.94E-01 -0.64 0.14 6.38E-06 
rs17817449 53813367 2121 0.20 0.10 4.76E-02 -0.65 0.14 4.32E-06 
rs9972653 53814363 2120 0.25 0.10 1.65E-02 -0.63 0.14 8.75E-06 
rs11075987 53815161 2125 -0.12 0.10 2.17E-01 -0.64 0.14 7.57E-06 
rs17817497 53815435 2123 0.23 0.10 2.53E-02 -0.65 0.14 5.35E-06 
rs8050136 53816275 2124 0.22 0.10 3.05E-02 -0.64 0.14 6.38E-06 
rs4783819 53816647 2123 -0.14 0.10 1.72E-01 -0.64 0.14 7.04E-06 
rs8051591 53816752 2124 0.23 0.10 2.44E-02 -0.63 0.14 8.40E-06 
rs9935401 53816838 2120 0.22 0.10 3.13E-02 -0.64 0.14 7.02E-06 
rs9933509 53818167 2121 0.24 0.10 2.05E-02 -0.64 0.14 8.05E-06 
rs3751812 53818460 2127 0.23 0.10 2.44E-02 -0.65 0.14 5.79E-06 
rs3751813 53818708 2129 -0.26 0.10 1.12E-02 -0.64 0.14 6.38E-06 
rs3751814 53818724 2129 0.23 0.10 2.62E-02 -0.65 0.14 4.74E-06 
rs9931900 53818813 2125 0.24 0.10 1.86E-02 -0.64 0.14 7.10E-06 
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rs9936385 53819169 2128 0.23 0.10 2.27E-02 -0.64 0.14 6.58E-06 
rs9923233 53819198 2121 0.23 0.10 2.64E-02 -0.63 0.14 1.00E-05 
rs9923312 53819367 2124 0.22 0.10 3.16E-02 -0.65 0.14 5.86E-06 
rs11075989 53819877 2122 0.22 0.10 3.41E-02 -0.64 0.14 6.36E-06 
rs11075990 53819893 2123 0.22 0.10 2.81E-02 -0.64 0.14 6.33E-06 
rs11075991 53819937 2122 0.23 0.10 2.78E-02 -0.64 0.14 7.93E-06 
rs11075992 53820066 2124 0.23 0.10 2.21E-02 -0.64 0.14 6.45E-06 
rs9926289 53820503 2122 0.22 0.10 2.89E-02 -0.64 0.14 5.97E-06 
rs9939609 53820527 2119 0.23 0.10 2.24E-02 -0.62 0.14 1.15E-05 
rs17817712 53821125 2124 0.23 0.10 2.22E-02 -0.64 0.14 7.68E-06 
rs7206410 53821297 2124 0.23 0.10 2.56E-02 -0.64 0.14 7.55E-06 
rs7206629 53821413 2125 0.25 0.10 1.46E-02 -0.64 0.14 6.18E-06 
rs7202116 53821615 2129 0.23 0.10 2.19E-02 -0.64 0.14 6.26E-06 
rs7202296 53821690 2123 0.24 0.10 2.10E-02 -0.63 0.14 8.63E-06 
rs7201850 53821862 2127 0.24 0.10 1.79E-02 -0.65 0.14 5.69E-06 
rs66908032 53822142 2129 0.23 0.10 2.41E-02 -0.64 0.14 6.76E-06 
rs72803697 53822183 2127 0.22 0.10 3.00E-02 -0.64 0.14 6.03E-06 
rs7185735 53822651 2123 0.23 0.10 2.62E-02 -0.64 0.14 6.39E-06 
rs62033406 53824226 2107 0.20 0.10 5.03E-02 -0.64 0.14 6.60E-06 
rs9941349 53825488 2125 0.23 0.10 2.08E-02 -0.65 0.14 4.58E-06 
rs7187961 53826034 2130 -0.26 0.13 4.39E-02 -0.63 0.14 8.40E-06 
rs10468280 53827479 2120 0.22 0.10 2.83E-02 -0.64 0.14 7.21E-06 
rs76442450 53827487 2129 -0.35 0.20 7.31E-02 -0.64 0.14 7.37E-06 
rs62033408 53827962 2124 0.21 0.10 3.93E-02 -0.63 0.14 8.23E-06 
rs73612051 53828037 2128 -0.39 0.20 4.57E-02 -0.63 0.14 9.19E-06 
rs17817964 53828066 2127 0.22 0.10 3.41E-02 -0.64 0.14 6.24E-06 
rs7190492 53828752 2127 -0.15 0.10 1.49E-01 -0.65 0.14 5.43E-06 
rs73607075 53828968 2130 -0.34 0.20 8.69E-02 -0.63 0.14 8.83E-06 
rs9930506 53830465 2124 0.23 0.10 2.56E-02 -0.65 0.14 5.61E-06 
rs9932754 53830491 2121 0.23 0.10 2.55E-02 -0.65 0.14 5.59E-06 
rs9933040 53830867 2120 0.22 0.10 2.99E-02 -0.65 0.14 5.99E-06 
rs9922708 53831146 2110 0.23 0.10 2.45E-02 -0.64 0.14 6.29E-06 
rs72805611 53831354 2122 0.20 0.10 5.01E-02 -0.64 0.14 6.72E-06 
rs9922619 53831771 2126 0.22 0.10 2.90E-02 -0.65 0.14 5.21E-06 
rs4783821 53834508 2129 -0.14 0.10 1.79E-01 -0.63 0.14 8.05E-06 
rs114078316 53834763 2121 0.05 0.15 7.59E-01 -0.65 0.14 4.59E-06 
rs11075993 53837144 2122 0.20 0.10 5.40E-02 -0.65 0.14 5.92E-06 
rs72805613 53837342 2129 0.21 0.10 4.26E-02 -0.64 0.14 6.26E-06 
rs62033415 53837369 2119 0.01 0.19 9.53E-01 -0.64 0.14 6.26E-06 
rs73607083 53838295 2128 -0.32 0.20 1.01E-01 -0.64 0.14 6.47E-06 
rs8044769 53839135 2125 -0.10 0.10 2.96E-01 -0.64 0.14 7.28E-06 
rs12149182 53841177 2124 -0.13 0.10 2.19E-01 -0.64 0.14 6.70E-06 
rs58239912 53842518 2127 -0.36 0.20 6.81E-02 -0.64 0.14 7.82E-06 
rs111357538 53842712 2130 -0.38 0.23 9.23E-02 -0.64 0.14 7.48E-06 
rs12149832 53842908 2123 0.20 0.10 4.78E-02 -0.65 0.14 5.09E-06 
rs17218700 53844579 2124 0.05 0.15 7.51E-01 -0.63 0.14 8.77E-06 
rs11642841 53845487 2119 0.14 0.10 1.68E-01 -0.64 0.14 6.38E-06 
rs1861867 53848561 2114 -0.20 0.10 5.25E-02 -0.64 0.14 6.92E-06 
rs11075994 53850079 2121 -0.18 0.11 1.03E-01 -0.63 0.14 9.62E-06 
rs1421090 53850170 2128 -0.02 0.11 8.91E-01 -0.65 0.14 5.80E-06 
rs5816908 53850412 2128 0.14 0.12 2.47E-01 -0.64 0.14 6.49E-06 
rs9939811 53850868 2119 0.26 0.11 2.13E-02 -0.65 0.14 5.91E-06 
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Supplementary Table 16:  AMY1 estimated copy-number effect by gender at different time points in 
the DESIR cohort, at recruitment (Year 0) and after 3, 6, and 9 years. 
 
 Females  Males  
 β (SE) P β (SE) P 
Year 0 -0.14 (0.04) 4.76E-04 -0.10 (0.04) 5.55E-03 
Year 3 -0.16 (0.04) 2.75E-04 -0.10 (0.04) 4.14E-03 
Year 6 -0.19 (0.04) 3.25E-05 -0.12 (0.04) 8.99E-04 
Year 9 -0.20 (0.05) 1.10E-05 -0.11 (0.04) 3.06E-03 
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Supplementary Figures 
 
 
 
 
 
Supplementary Figure 1: Quantile-quantile (Q-Q) plot of the famCNV test statistics for the 
GCAS in the Swedish discordant sib-pair sample set. GCAS was carried out between the transcripts 
and DNA-array probes lying within the transcript plus 30kb upstream and downstream, to encompass 
the coding regions and their internal and nearby regulatory regions. The Q-Q plot depicts the test 
statistics for all transcripts tested. The genomic inflation factor was 1.12, which was further corrected 
by genomic control.  
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Supplementary Figure 2: Q-Q plots of the combined GCAS-BMI (left) and GCAS-fat mass 
(right) analyses. We assessed the significance of joint association for both gene expression and each of 
BMI and fat mass over the whole set of 348,150 Illumina probes used for the GCAS analysis. The 
cnvi0020639 probe identified in our study was ranked in the top 43 most significant hits for BMI (P = 
5.50 x 10
-10
) and within the 33 most significant for fat mass (P = 1.85 x 10
-10
). The strong associations 
observed between transcript levels and Illumina probes (Supplementary Figure 1) drove the majority 
of the highest associations in the joint association analyses. However, among the top hits only 
cnvi0020639 and one additional probe also showed a nominal univariate P value of association of less 
than 0.05 with both fat mass and BMI. 
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Supplementary Figure 3: Boxplot of (left to right) expression levels of the amylase genes in adipose 
tissue, fat mass, and BMI, for subjects in the extreme upper and lower deciles of the cnvi0020639 Log 
R Ratio (LRR) distribution in the Swedish discovery sample. 
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Supplementary Figure 4: Scatterplots of BMI (blue) and DEXA fat mass (green) residuals, adjusted 
for sex and age, against Log R Ratio (LRR) at cnvi0020639 in the Swedish sample. 
  
24 
 
 
Supplementary Figure 5: Whole genome shotgun sequencing-based total copy-number estimates of 
the AMY genes versus copy-numbers estimated at AMY1 by qPCR. The analyses using data from the 
1000G project demonstrated a strong correlation between the two orthologous methods, r = 0.94, P < 2 
x 10
-16
. 
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Supplementary Figure 6: Whole genome shotgun based total copy-number estimates versus qPCR 
based copy-number estimates for each of the amylase paralogs. Highly homologous AMY1A1, 
AMY1A2, AMYP, AMY1A3 and AMY2A are strongly correlated with the qPCR based copy-number 
estimates while the more divergent AMY2B paralog is not. 
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Supplementary Figure 7: Paralog specific copy-number estimates for 34 individuals are plotted 
versus the qPCR based total AMY1 copy-number estimates. As expected AMY2A and AMY2B exhibited 
little correlation with AMY1 copy-number estimated by qPCR, while variation correlated with the total 
AMY1 qPCR copy-number estimates was observed for all the AMY1 paralogs. Within these 34 
individuals AMY1A2 was the most variable paralog. 
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Supplementary Figure 8: The sum of read depth based paralog specific copy-number estimates of 
each of the AMY1 paralogs is plotted versus the total AMY1 copy-number estimated by qPCR, r=0.59, 
P=2.71 x 10
-4
.  
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Supplementary Figure 9: A: total copy-number estimates of the AMY1 gene assessed by qPCR using 
an alternative assay (assay 2) versus copy-numbers estimated at AMY1 by the qPCR assay used in this 
study (assay 1) (r = 0.98, P < 2 x 10
-16
). B: total copy-number estimates of the AMY1 gene assessed by 
digital PCR versus copy-numbers estimated at AMY1 by the qPCR assay used in this study. The 
analyses show a strong correlation between the two methods, r = 0.95, P < 2 x 10
-16
. 
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Supplementary Figure 10: Copy-number and allele frequency distributions at AMY1 in TwinsUK 
(black bars) and DESIR (grey bars). Estimates in TwinsUK were calculated using a random unrelated 
subsample. Allele frequencies were estimated through the EM algorithm implemented in CoNVEM26 
(http://apps.biocompute.org.uk/convem/). See also Table 2 and Supplementary Table 4. 
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Supplementary Figure 11: Salivary (left) and pancreatic (right) serum amylase levels (IU/L) against 
estimated AMY1 copy-number distribution inferred through qPCR for 468 subjects of the ABOS 
sample. 
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Supplementary Figure 12: Age and sex adjusted BMI residuals against salivary and pancreatic 
amylase levels in serum (IU/L) for 468 subjects of the ABOS sample. 
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Supplementary Figure 13: A multiallelic CNV region on chromosome 1 overlapping the amylase 
gene cluster. An eleven-point scrolling average is plotted for samples in the top and bottom 10% of the 
log2 ratio distribution from Conrad et al (2010)
17
. Samples with an apparent deletion relative to the 
reference sample are depicted in red and samples with an apparent duplication relative to the reference 
are depicted in green. A sample showing no difference in copy-number from the reference sample is 
plotted in black. The boundaries of this region, as reported in the Database of Genomic Variants 
(http://projects.tcag.ca/variation/) by the authors are chr1:104,136,714-104,317,018. The region 
encompasses AMY2A, and AMY1A/B/C. 
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Supplementary Figure 14: Regional Manhattan plot of SNP association results in the amylase region 
from the latest BMI meta-analysis conducted by the GIANT consortium (Speliotes et al, 2010).  X-
axis: Chromosome 1 genomic coordinates. Y-axis: minus log10 (P value). Plot generated using 
LocusZoom
1
.  
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Supplementary Figure 15: PCR efficiency for the FAM (squares) copy-number target (AMY1) and 
VIC (diamonds) reference (RNAse P) assays. Assays showed comparable PCR efficiencies of 92.46% 
and 93.17%, respectively. X-axis: Log10(starting DNA quantity) of the DNA template. Y-axis: Mean 
threshold cycle (Ct). 
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Supplementary Figure 16: Q-Q plots of the association results of BMI with 21,877 DNA-array CNV 
probes in the TwinsUK sample. The cnvi0022844 probe contained in the amylase region and found to 
be associated with BMI in this sample was ranked among the top 32 hits.  
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Supplementary Figure 17: Locations of paralogs in the amylase region. The loci chosen for the 
copy-number prediction from whole genome-shotgun sequencing in a panel of 36 individuals 
sequenced as part of the 1000 Genomes Project were selected to span each of the paralogs (on the top 
of the figure, from left to right: AMY2B, AMY2A, AMY1A1, AMY1A2, AMYP, AMY1A3). Regions were 
targeted to maximize the number of SUNKs. 
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Supplementary Figure 18: Effect of qPCR-inferred AMY1 copy-number on BMI in females (left) and 
males (right) at different time points in the DESIR cohort, namely at recruitment (Year 0) and after 3, 
6, and 9 years. 
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Supplementary Figure 19: Flow chart of experimental design  
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Supplementary Methods 
1. Study cohorts 
 
Summary information for all samples included in this study is presented in Table 1. 
The studies were approved by the relevant institutional review boards in Sweden, UK, 
and France, and were conducted according to the principles of the Declaration of 
Helsinki. Written informed consent was obtained from every participant in each 
study. 
 
1.1. Swedish families 
The discovery sample included 154 Swedish families (651 subjects) ascertained 
through the presence of an obesity-discordant sib-pair in each family (body mass 
index [BMI] difference > 10 kg/m
2
)
2
. Gene expression and DNA-array data were 
available for 149 families (342 subjects). Average family size was 4.34. Gene 
expression was measured in subcutaneous adipose tissue (SAT) using the Affymetrix 
Human Genome U133 Plus 2.0 microarrays. DNA from peripheral blood was 
genotyped in the same set of samples using the Illumina 610K-Quad array. 
Normalized intensity data were extracted using the Illumina GenomeStudio software, 
specifically the log R ratio (LRR), representing the total fluorescent intensity signals, 
and the B Allele frequency (BAF), representing the proportion of the total signal 
deriving from the B allele. Normalised intensity data from a total of 348,150 probes 
were included in our GCAS analysis. The single nucleotide polymorphisms (SNPs) in 
the amylase gene cluster region (n=12) were all in Hardy Weinberg equilibrium 
(HWE). Sample homogeneity was verified through Principal Component Analysis 
(PCA) using genotype data for 28,731 unlinked SNPs. Copy-numbers at AMY1 and 
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AMY2 were estimated by quantitative real-time PCR (qPCR) for 481 subjects with 
complete data on both BMI and dual-energy X-ray absorptiometry (DEXA)-derived 
fat mass (see Section 2). Samples were plated in triplicate. To avoid spurious 
associations resulting from possible batch effects the samples were plated to ensure 
equal BMI distribution across plates (P value from Kruskal-Wallis test = 0.13). 
 
1.2. TwinsUK  
The St. Thomas' UK adult twin registry (TwinsUK) cohort is unselected for any 
disease or medical condition and is representative of the general UK population
3
. All 
subjects were recruited through national media campaigns and historically have 
included mostly females. To analyse signal intensity data from genome-wide SNP 
arrays in this sample, we selected the largest available uniform dataset of genotyping 
data from the TwinsUK cohort generated using the same genotyping platform, which 
consisted of 972 female subjects genotyped on the Illumina 610K-Quad array 
(Illumina)
4
. GWAS genotyping in the TwinsUK cohort was carried out in several 
stages over the years using different DNA-arrays, a number of which did not contain 
probes within the AMY1 gene. Even for those chips containing probes within AMY1, 
while genotype calls can safely be combined from different GWAS batches, the same 
is not true for raw DNA-array intensity data. This is due to the fact that experimental 
batch effects between samples genotyped at different stages (and on different DNA-
array chips) can be highly challenging to remove from such data, thus hampering 
CNV association studies. In order to avoid batch effects resulting from experimental 
differences both at the genotyping plate and at the experiment-level, we therefore 
focused our analysis of Illumina data in the TwinsUK cohort on the largest batch of 
data generated in a single genotyping experiment for this study sample (a total of 972 
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samples). The remaining genotyping experiments either included small numbers of 
subjects per-experiment and were genotyped on different chips, or were genotyped on 
the Illumina Hap300 chip which did not contain probes within the amylase region. 
Intensity signals from 35 probes encompassing the amylase cluster region were 
included in our analyses. Normalised signal intensity data were extracted using the 
Illumina GenomeStudio software.  
Replication of the association with BMI was carried out using 1,479 independent 
female samples with normal fasting glucose levels (<6.1 mmol/l) from the TwinsUK 
cohort.  
DNA quality has repeatedly been shown to affect copy-number estimation from qPCR 
data
5-7
, and we focused this experiment on those subjects collected after 2001, due to 
the fact that different extraction methods had been used in the previous years (Phenol-
chloroform, salting out methods) and extraction was sometimes outsourced. 
Beginning in 2001, genomic DNA for the TwinsUK cohort was extracted in-house 
using a Nucleon BACC3 kit (Nucleon Biosciences, Coatbridge, UK). AMY1 copy-
number was inferred by qPCR as described in Section 2. Samples were plated in 
sextuplicate ensuring BMI homogeneity across plates, to avoid potential batch effects 
resulting from correlation between BMI and sample plate (P-value from Kruskal-
Wallis test = 0.70). 
 
1.3. DESIR  
The Data from the Epidemiological Study on the Insulin Resistance syndrome 
(DESIR) study is a longitudinal study recruited through the French national social 
security system in western-central France between 1994-1996
8
. Sample homogeneity 
in DESIR was verified through PCA analysis based on genotyping data for 39,000 
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SNPs measured using the Illumina MetaboChip assay (data not shown). BMI 
association analysis in the DESIR sample was carried out using 2,137 normo-
glycaemic subjects (fasting glucose levels <6.1 mmol/l) and unlikely to be affected by 
metabolic disorders (based on drug prescription records), representative of the general 
French population. To ensure the best DNA quality, we freshly extracted the DNA 
from the year-6 time-point of this longitudinal cohort. AMY1 copy-number was 
inferred by qPCR as described in Section 2. In this sample, we opted to genotype each 
sample twice using four replicates each time (total = 8 measurements per sample). 
Copy-number concordance
9,10
 between replicated plates was > 0.99 (P < 2.0 10
-16
). 
We designed the plating taking care to avoid correlation between BMI and sample 
plate that could potentially generate spurious association (P-value from Kruskal-
Wallis test = 0.26). Longitudinal BMI observations were available for 4 time points, 
at recruitment and after 3, 6, and 9 years.  
 
1.4. French adult obesity cases (AOB) 
The adult obesity study is fully described elsewhere
11
. Copy-numbers at AMY1 were 
estimated by qPCR for 205 obese cases (BMI ≥ 30kg/m2) and 358 age-matched 
controls (BMI < 25 kg/m
2
) (see Section 2). Subjects were selected to have age not 
greater than 45 years and plasma fasting glucose levels less than 6.1 mmol/l. Samples 
were plated in triplicate. To avoid potential batch effects cases and controls were 
randomly mixed in each plate in equal proportion across all plates. Dixon’s Q test was 
not significant for both the number of cases (P = 0.36) and controls (P = 0.90) and for 
the case/control ratio (P = 0.21) across plates.  
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1.5. ABOS 
ABOS (Atlas Biologique de l’Obésité Sévère) is an on-going French cohort study 
(ClinicalTrials.gov Identifier: NCT01129297) conducted by the Département de 
Chirurgie Générale et Endocrinienne (Lille CHRU). The vast majority of the ABOS 
participants were severely obese and all were candidates for bariatric surgery. Copy-
number inference at AMY1 and AMY2 through qPCR (see Section 2) was successful 
for 468 subjects, of whom 441 were obese with BMI ≥ 30 kg/m2. Samples were plated 
in triplicate. We designed the plating taking care to avoid correlation between BMI 
and sample plate that could potentially result in spurious associations (P-value from 
Kruskal-Wallis test = 0.14). 
Serum pancreatic and salivary amylase levels for 468 patients were measured by an 
enzymatic colorimetric assay with an autoanalyzer (CoBAS Icobas® 8000 modular 
analyser series; kits AMYL2-03183742122 and AMY-P-20766623322, Hoffman-La 
Roche Ltd). 
1.6 Singapore Prospective Study Program (SP2) 
SP2
12
 is a population-based, cross-sectional study of 2,431 adult Singaporean subjects 
(Singaporean Chinese, Malays and Asian-Indians), aged between 24 and 95 years and 
this study that was specifically designed to examine the pathogenesis of 
cardiovascular and metabolic diseases. All individuals provided informed consent. 
Anthropometric measurements were performed by trained professionals at the clinics.  
Weight and height were measured in light clothing with no shoes.  BMI was 
calculated as weight (in kg) over height (in m) squared. For this study we analysed 
136 obese (BMI > 28 kg/m
2
), 197 overweight (23 ≤ BMI ≤ 28 kg/m2), and 325 
normal-weight controls with BMI < 23 kg/m
2
 from the 2,431 adult Singaporean 
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Chinese individuals included in SP2. AMY1 copy number was measured by qPCR in 
all 658 subjects. 
2. Copy-number estimation by quantitative real-time PCR 
AMY1 and AMY2A gene copy-number were estimated by duplex quantitative real-time 
PCR (qPCR) on an Applied Biosystems 7900HT Real-Time PCR System, with 
Sequence Detection Software (SDS) version 2.3. Duplex reactions consisted of two 
assays, each with two primers and a TaqMan probe (Life Technologies); one specific 
for the target, AMY1 (Hs07226362_cn) and AMY2A (Hs04204136_cn), and one 
specific for the reference (RNase P). The primers and probe of the Taqman qPCR 
assay employed in our analyses specifically target a region within exon 1 of the AMY1 
gene, which is absent in the AMYP1 pseudogene, therefore ensuring specificity of the 
qPCR assay for AMY1. Values extracted following analysis with the SDS software 
were analysed with CopyCaller v1.0 software (Applied Biosystems), using analysis 
settings selected as recommended in the user guide. Diploid copy-numbers were 
estimated by ΔΔCt method using the reference DNA sample NA18972 (Coriell Cell 
Repositories, Camden, NJ), which carries 14 copies of the AMY1 gene
13
 and 2 copies 
of AMY2
14
, and which was also used for between-experiment normalization. The 
sample NA18972 was specifically selected as a reference sample due to the fact that 
its copy number had been independently measured and confirmed in several published 
studies using methods including fiberFISH, qPCR and next-generation sequence 
analysis
13,14
.  AMY1 copy-number inference in both the TwinsUK and in the DESIR 
population sample was performed using an additional reference sample NA18956 
which had been determined to carry 6 copies of the AMY1 gene both by Perry et al
13
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and through the analysis of whole genome-shotgun sequencing data from the 1,000 
Genomes Project (see Section 3.7).  
The ΔΔCt method assumes equal amplification efficiency for the target and the 
reference genes. PCR efficiency was evaluated for the target AMY1 assay and the 
reference RNase P assay using a standard curve of serial dilutions of a DNA sample 
of known concentration. Log10 of the dilution factor was plotted against Ct mean 
values for each of the two assays. The slope of the line was then used to calculate 
PCR efficiency for each assay as follows:  
E = 10
(-1/slope)
 
PCR Efficiency (%) = (E – 1) x 100 
PCR efficiency for the target (AMY1) and reference (RNase P) assays was 92.46% 
and 93.17%, respectively (Supplementary Figure 15). 
We further compared copy-number at the AMY1 gene predicted using the qPCR assay 
to those predicted from whole-genome shotgun sequencing (section 3.7 of this 
document), as well as by digital PCR and using an alternative qPCR assay (section 
3.8 of this document), showing strong correlation between the qPCR copy number 
measurements and those generated using each of the two other methods. 
 
2.1. Quality control of large-scale population qPCR data  
While quality control procedures have been standardized and are globally accepted 
for large genetic epidemiology studies such as GWAS, few large-scale qPCR-based 
CNV studies have been carried out to date. The quality control measures applied to 
qPCR data are aimed at identifying outliers for ΔCt values and their standard 
deviation among technical replicates (ΔCtSd) that can reflect differential DNA 
qualities or other possible technical issues. Of particular importance are those errors 
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affecting the calibrator sample, which in the ΔΔCt method is used to predict the copy-
number state for all samples present in the same plate, and are thus likely to have an 
even stronger impact on the association study through their potential to induce batch 
effects in the data. Therefore, we designed our experiments to include two different 
calibrators on each plate on the two different tails of the copy-number distribution 
(see the previous section), both used for copy-number estimation to allow two 
additional quality control checks. At the plate level, we removed potential random 
fluctuations in the calibrators’ ΔCt assignments (which may alter copy-number 
prediction for all samples in the same plate) by filtering out plates on the lowest 5% of 
the concordance correlation coefficient distribution calculated between copy-number 
states inferred by each of the two calibrators using the epiR R library
9,10
. At the 
sample level we then further removed those individual samples whose copy-number 
prediction was discordant for each of the two calibrators.  
Since the DESIR experiment was designed using duplicate plates, the concordance 
was assessed between duplicate plates, and the predicted copy-number state was 
calculated by averaging the predictions between duplicate plates.  
Furthermore, we assessed whether the use of integer predicted copy-numbers derived 
from non-integer calculated copy-numbers could in any way be resulting in spurious 
associations arising from rounding differences which could be cryptically associated 
with the phenotypic outcome. We tested each dataset (for both the BMI and obesity 
analyses) for association between the differences between exact and integer copy-
numbers (referred to as residuals by Hollox et al
6
) and the phenotypic outcome (BMI 
or obesity). No association was observed between these copy-number 'residuals' and 
the phenotypic outcome in any of our datasets (association results are reported in each 
analysis section of this Appendix).  
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3. Statistical analyses 
Unless indicated otherwise, statistical analyses were carried out using R version 
2.13.1
15
. All genomic coordinates are based on the February 2009 assembly of the 
human genome (hg19/GRCh37).  
3.1. Gene-centric CNV association analysis 
Gene-centric association (GCAS) was carried out using the linear mixed effects 
model implemented in famCNV, modelling gene expression levels in adipose tissue 
against genotype signal intensities
16
. famCNV, rather than inferring the discrete 
number of copies of a region, uses the continuous distribution of the intensity signals 
from SNP arrays to model the correlation with quantitative phenotypes in families
16
. 
As quantitative traits, we selected 29,546 transcripts (corresponding to 16,563 
ENSEMBL genes) with known position in the genome and specificity > 70%. For 
each transcript, we focused the analyses on those probes lying within the transcript 
plus 30kb upstream and downstream, to encompass the coding regions and their 
internal and nearby regulatory regions (348,150 probes). The median (1st-3rd 
quartile) number of markers tested per transcript was 19 (12–33). Age and sex were 
included as covariates in the analyses. We applied the genomic control method to 
correct for inflation of the test statistics. Association P values were corrected for 
multiple testing using the False Discovery Rate (FDR) q-value method
17
 in the gene-
centric association analysis. See Supplementary Table 1, Figure 1, Supplementary 
Figure 1. 
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3.2. aCGH data exploration 
High-resolution array comparative genome hybridization (aCGH) data for 40 
individuals
18
 were obtained from the Wellcome Trust Sanger Institute, U.K.: 
(http://www.sanger.ac.uk/cgi-bin/humgen/cnv/42mio/downloadBigDB.cgi).  
An eleven-point scrolling average was calculated for log2 ratios for probes between 
104.0Mb and 104.4Mb, encompassing a CNV region overlapping the amylase gene 
cluster. Samples in the top and bottom deciles of the log2 ratio distribution were 
plotted to visualize the CNV boundaries at this locus (Supplementary Figure 13).  
 
3.3. CNV analysis of BMI and fat mass in the Swedish sample 
Probes identified in the GCAS were tested in the Swedish sample against BMI and for 
a subgroup of 331 subjects with dual-energy X-ray absorptiometry (DEXA)-derived 
fat mass data using the mixed linear model implemented in famCNV. We selected, 
among the 131 SNP-chip probes showing significant association at 10% false 
discovery rate (FDR) in the GCAS (Supplementary Table 1), a subgroup of 81 
probes located in genes where at least two associations between CNV and gene 
expression in adipose tissue were detected. Age and sex were included as covariates. 
Wilcoxon tests were assessed on BMI, fat mass, and amylase gene expression 
residuals, adjusted for age, sex and family clustering, between the top and bottom 
deciles of the LRR distributions for the associated probe cnvi0020639 
(Supplementary Figure 3). 
 
3.4. Joint analysis of the GCAS and each of BMI and fat mass 
To assess the significance and ranking of our finding at the genome-wide scale, we 
performed joint association analysis for both gene expression levels in adipose tissue 
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and each of BMI and fat mass over the whole set of 348,150 Illumina probes used in 
the GCAS analysis. We first carried out CNV association analyses with famCNV for 
each of BMI and fat mass in the Swedish sample using the entire set of Illumina 
probes. We then combined the results from each of the two analyses with the GCAS 
results to assess the joint association at each probe with both expression levels of the 
overlapped gene and each of BMI and fat mass. We applied the method described by 
Brown
19
, to account for the correlation between gene expression levels and each of 
the two phenotypes. Brown’s method19 provides an extension to Fisher's method 
when the variables, and therefore the tests, are not jointly independent. This method 
aggregates multiple dependent tests by assuming a multivariate normal distribution of 
the traits (and therefore of the tests) with a known covariance structure, and is 
appropriate in our study where one-sided likelihood ratio tests of association (such as 
those assessed by famCNV) are combined (Supplementary Figure 2).  
 
3.5. BMI copy-number association analyses with LRR data in TwinsUK 
Association analysis of LRR data from the Illumina platform with BMI was carried 
out in the TwinsUK cohort in a linear mixed effects model framework, including 
family structure and genotyping plate as random effects. LRR and BMI values were 
averaged within monozygous twin pairs to reduce measurement errors and 
environmental effects. Age and sex were included as covariates. To better refine the 
CNV localization by weighting information provided by each probe, the association 
tests were also assessed using the first principal component calculated from the 
intensity data of consecutive probes in the region of interest using a sliding window of 
variable size ranging from a minimum of 2 probes to encompassing all probes across 
the region. Difference in BMI between the top and bottom deciles of the LRR 
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distributions for the associated cnvi0022844 probe was assessed using the Wilcoxon 
test. We investigated any potential bias of the association with the cnvi0022844 CNV 
probe by carrying out genome-wide association in the TwinsUK sample using all 
CNV probes on the Illumina 610k-Quad array (n=21,887) (Supplementary Figure 
16). 
 
3.6. Association of qPCR-estimated copy-number with quantitative traits in the 
Swedish sample 
Estimated copy-number at AMY1 and AMY2 was inferred by qPCR for 481 subjects 
(478 for AMY2) from the Swedish families for whom complete data on both DEXA 
fat mass and BMI were available (236 parents and 242 siblings). A linear mixed 
effects model, implemented in the lmekin function from the R kinship package
20
, was 
used to carry out association analysis between copy-numbers at each of AMY1 and 
AMY2 with each of BMI and fat mass, including the kinship matrix, calculated among 
all subjects, in the random effects to correct for relatedness among family members. 
Sex and age were included as covariates. Copy numbers included in the association 
analyses were restricted to those observed at a frequency above 1% in our study 
sample. Results are shown in Supplementary Table 2. 
 
3.7. Amylase copy-number estimation by whole genome sequencing  
To validate the amylase qPCR-based CNV assay, we compared total AMY1 copy-
number estimated by qPCR to those estimated from whole-genome shotgun 
sequencing in a panel of individuals sequenced as part of the 1000 Genomes Project 
Phase I. We focused on a diverse panel of 36 individuals sequenced on the Illumina 
platform. Two individuals, namely NA18972 and NA18956 were used as calibrators. 
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Specifically, we employed two approaches, total copy-number genotyping, which 
estimates the total copy-number of all of the genes within the family, and paralog-
specific SUN (singly unique nucleotide) based genotyping, across the six AMY 
paralogs (including one pseudogenized copy) in the reference genome
14,21
 
(Supplementary Table 3; Supplementary Figure 5). 
The total sequencing coverage of these individuals ranged from 2.6×-14.6× coverage 
(median, 5.23× coverage). Whole-genome Illumina shotgun sequenced reads from 
individuals were mapped to the repeat-masked human reference genome (Build 
hg19/GRCh37) using the mrsFASTc alignment software
22
 and normalized for GC 
content. A calibration curve was then constructed over regions of known copy-
number and was used to estimate copy-numbers at additional loci in each individual. 
More details can be found in the cited references.  
Total copy-number estimation across the AMY1A1 gene demonstrated that the qPCR 
and sequencing-based copy-numbers were highly concordant, with a correlation of 
r=0.94 between the two orthologous methods (Supplementary Figure 5). As the total 
copy-number genotyping method is estimating the aggregate copy-number of all 
members of the gene family, similarly high correlations were observed over each of 
the highly homologous paralogs AMY1A2 and AMY1A3 and AMY2A with r=0.95, 
r=0.96, r=0.94 respectively. AMY2B, which is a more ancient copy of amylase and 
further diverged from the other copies, showed no correlation with the qPCR assay 
(r=-0.19; Supplementary Figure 6). The concordance of these two independent 
methods demonstrates that each is able to estimate copy-number over a large dynamic 
range and provides validation for the AMY1 qPCR assay. 
To determine which of the individual paralogs was varying (Supplementary Figure 
17), we next performed SUNK-based paralog-specific inference across each of the 
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amylase copies (Supplementary Figure 7). Paralog specificity was achieved by 
considering reads only mapping to singly unique k-mers (SUNKs), which are 
sequence k-mers that are unique within the genome and thus specifically tag a 
location. As the individual AMY paralogs are highly homologous, the number of 
SUNKs tagging the individual paralogs is few and thus the results are less precise. For 
example, we identify only 25 SUNKs for AMY1A2, limiting the number of reads that 
can be used to accurately infer copy number (Supplementary Table 3).  However, 
while the qPCR-based assay is specific to AMY1, the SUNK based copy-number 
estimates were able to distinguish between each of AMY1A1, AMY1A2 and AMY1A3 
in addition to the AMYP pseudogene. As expected, there was no correlation between 
either the AMY2A or the AMY2B paralogs with the AMY1 qPCR assay (P>0.05) 
(Supplementary Figure 7). Additionally, little copy-number variation was observed 
among these 34 individuals in the AMY2 paralogs. The correlation between the qPCR 
assay and the total copy-number of all the AMY1 paralogs estimated using the SUNK-
based method was 0.59 (P=2.71 x 10
-3
) (Supplementary Figure 8), providing further 
validation for the qPCR assay. Additionally, the SUNK-based copy-number analysis 
demonstrated that among these 34 individuals AMY1A2 was the most variable 
paralog. 
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3.8. Amylase copy-number estimation by digital PCR (dPCR) and alternative 
qPCR assay 
Digital PCR analysis was performed on the BioMark System (Fluidigm) on 96 
samples from the DESIR cohort, using the qdPCR 37K Digital Array (Fluidigm), 
according to manufacturer’s recommendations. This digital array consists of 48 
panels, each containing 770 individual reaction chambers. Briefly, the final reaction 
mix for a digital panel comprised 1.2µL DNA (at 5ng/µL; this concentration was 
measured using the Qubit dsDNA HS Assay kit [Invitrogen]), 2µL TaqMan Gene 
Expression Master Mix (Applied Biosystems), 0.4µL 20x GE Sample Loading 
Reagent (Fluidigm), 0.2µL AMY1 TaqMan assay (Hs07226362_cn; Applied 
Biosystems) and 0.2µL RNase P human TaqMan Copy Number Reference (Applied 
Biosystems). A total of 10µL of 1× GE Sample Loading Reagent (Fluidigm) with 4µL 
sample mix were aliquoted into each sample inlet on the digital array and were 
distributed throughout the partitions within each panel using an automated IFC 
controller-MX (Fluidigm). Each DNA sample was analysed in quadruplicate, with 
single replicate outliers removed.  Inferred copy-numbers at AMY1 showed high 
correlation between qPCR and digital PCR (r=0.95; P<2.20 x 10
-16
; Supplementary 
Figure 9). We additionally measured copy numbers at AMY1 using an alternative 
qPCR assay (Hs07226361_cn; Applied Biosystems) targeting a region within exon 1 
of the AMY1 gene, which is absent in the AMYP1 pseudogene, therefore ensuring 
specificity of the qPCR assay for AMY1. The entire set of 96 DESIR samples was 
analysed in duplicate plates, with each sample analysed in triplicate on each of the 
duplicate plates (total = 6 measurements per sample). Inferred copy-numbers at AMY1 
were again highly correlated between our qPCR assay and the qPCR results using the 
alternative assay (r=0.98; P<2.20 x 10
-16
; Supplementary Figure 9). 
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3.9. qPCR copy-number association analyses in the TwinsUK and DESIR 
population samples 
To finely quantify at the highest resolution the relationship between BMI and 
estimated copy-number at the AMY1 gene in the continuous BMI distribution of this 
unselected population sample, we carried out detailed BMI analyses in 1,479 female 
twins from the TwinsUK cohort and 2,137 subjects from the DESIR cohort. The case-
control obesity association studies in these samples were carried out on the subset of 
samples from these cohorts with BMI ≥30 and <25 kg/m2. In both the TwinsUK and 
DESIR samples, copy-number was predicted using two qPCR calibrator samples, one 
at each end of the copy-number distribution (NA18956 CN = 6 and NA18972 CN = 
14). Estimated copy-numbers higher than 13 (showing frequency < 2.5%) were 
collapsed together into a single category. In TwinsUK, the association between either 
BMI or obesity and estimated integer copy-numbers at AMY1 was tested using a 
mixed effects model with age as a covariate and including family and genotyping 
plate as random effects. In DESIR the association between either BMI or obesity and 
estimated integer copy-numbers at AMY1 was tested using a mixed effects model with 
age and sex as covariates and including genotyping plate as a random effect. Gender-
stratified analyses were also conducted where association between either BMI or 
obesity was assessed separately in males and females using a mixed effects model 
with age as a covariate and including genotyping plate as a random effect. Results are 
reported in Table 2, Supplementary Tables 6-9 and Section 3.9. 
In both studies, we also calculated empirical P values through 10,000 random 
permutations of the copy-number state across subjects while retaining the phenotypic 
information and observing the number of times (n) the observed association was 
equated or exceeded by chance. The empirical P value, calculated as (n + 1)/10,001, 
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was significant for both TwinsUK (P = 5.00 × 10
-4
) and DESIR (P = 2.00 × 10
-4
).  
To determine whether rounding of the estimated copy-number to the closest integer 
value could be resulting in any spurious association, we carried out associations with 
both the residuals (integer value - calculated value) and its absolute value against 
both BMI and obesity. Associations were not significant for either BMI in TwinsUK 
(P = 0.20; Pabsolute = 0.25) and DESIR (P = 0.60; Pabsolute = 0.79) or for obesity in 
TwinsUK (P = 0.12; Pabsolute = 0.56) and DESIR (P = 0.46; Pabsolute = 0.59). 
Additionally, inspired by the approach described by Field et al
23
, we also conducted 
the association analyses using the alternative approach of applying unsupervised 
clustering (k-means) to divide the raw ΔCt signal into discrete categories, obtaining 
comparable results - correlation between inferred copy-number and raw signal 
discretized by k-mean clustering in TwinsUK was r > 0.98; P < 2.2 × 10
-16 
and in 
DESIR was r > 0.95; P < 2.2 × 10
-16
. 
In both TwinsUK and DESIR, the association with obesity between carriers of low 
and high copy-numbers was carried out using a binary variable to categorize subjects 
below and above the first (≤3 copy-numbers) and last (≥10 copy-numbers) decile of 
the estimated copy-number distribution, respectively (Supplementary Table 10).  
 
3.10. Longitudinal Analysis and Sex-Specific Effects in DESIR 
Interaction between age and copy-number at AMY1 in DESIR was carried out by 
comparing the fit of the null mixed models which included a random effect for 
intercept and slope where the individual BMI at the 4 time points was determined by 
the additive effects of age and estimated copy-numbers (both transformed into z-
scores), and the full model which also included the age × copy-number interaction 
term (see also Supplementary Table 16; Supplementary Figure 18). Significant 
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interaction was observed between AMY1 estimated copy-number and subject age, 
showing an increased effect of AMY1 estimated copy-number on the individual’s BMI 
throughout life. The interaction between subject age and AMY1 estimated copy-
number was significant only in females (Pfemales = 5.38 × 10
-3
, Pmales = 0.21).  
The longitudinal study between AMY1 estimated copy-number and BMI comprised 
four times more observations (4 observations per individual) than the cross-sectional 
analysis. Given the limited sample size, the latter analysis was therefore slightly 
underpowered to detect both main effects and interactions with this highly 
polymorphic locus. Comparison of a simpler null model (no interaction between 
estimated copy-number and sex) of longitudinal association between AMY1 estimated 
copy-number and BMI including both males and females (with sex as a covariate) 
against an alternative model that includes also the interaction term between estimated 
copy-number and sex, against an alternative model that includes also the interaction 
term between estimated copy-number and sex was highly significant (P<2.20 × 10
-16
). 
The longitudinal interaction between sex and estimated copy-number at AMY1 was 
indeed significant, with P = 1.71 × 10
-3
. In summary, while a baseline effect was 
detected for BMI in males (cross-sectional P = 1.92 × 10-3), as also showed in 
Supplementary Figure 18 BMI in females appeared to be more strongly affected by 
estimated copy-number at AMY1 throughout life.  
In our cross-sectional analyses, although there was no significant difference in the 
CNV distribution between male and female subjects (P = 0.96), when the meta-
analysis of the DESIR and TwinsUK cohorts was carried out only in the female 
subsample (n=2,674), we found a stronger effect of estimated AMY1 copy-number on 
BMI (for each additional copy of AMY1: β = -0.18 [0.03] kg/m²; P = 9.38 × 10-8; 
Table 1). 
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Analogously, meta-analysis of the three TwinsUK, DESIR and AOB case-control 
studies (593 cases; 2,336 controls) suggested the existence of a stronger effect of 
estimated AMY1 copy-number on obesity risk in females (per AMY1 copy-number: 
OR = 1.22 [1.15-1.30]; P = 8.87 × 10
-10
 in females; OR = 1.12 [1.02-1.24]; P = 1.86 × 
10
-2
 in males). 
While it is essential to note that our cross-sectional study samples were underpowered 
to detect interaction effects between estimated AMY1 copy-number and sex, our 
analyses suggest that potential sex-specific effects between estimated AMY1 copy-
number and adiposity may exist, and may be worthy of further assessment in larger 
replication samples. 
 
3.11. FTO association study 
We aimed to contrast the effect of AMY1 estimated copy-number on BMI variation 
with that of FTO, which is the locus showing the strongest, most replicated genetic 
association with BMI. We carried out BMI association analyses using all SNPs 
included in the haploblock on chromosome 16q12.2 (chr16: 53,797kb-53,850kb), 
where previously-reported associations with FTO have largely been identified
22
. 
Eleven genotyped and imputed SNPs were included in the TwinsUK cohort for a 
subset of 1,388 subjects genotyped on the Illumina Hap300 and 610K-Quad arrays
22
.  
The DESIR cohort has recently been genotyped with the Illumina MetaboChip and 
data for 104 SNPs were available for 2,132 subjects from this study. 
For comparison, association between estimated copy-numbers at AMY1 and BMI was 
assessed for the subgroups of subjects also genotyped at each tested SNP, and AMY1 
estimated copy-numbers were dichotomized into low (<6) or high (≥6) categories.  
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The most significant association in the FTO region in TwinsUK was observed at 
rs3751812 (β [se]= 0.45[0.18] kg/m²; P = 1.44 × 10-2) while AMY1 estimated copy-
number association for the same subset of subjects showed a level of significance two 
orders higher and a stronger effect (β [se] = -0.86 [0.25] kg/m²; P = 5.52 × 10-4; 
Supplementary Table 14). In DESIR the most significant association observed at the 
FTO locus was at the SNP rs3751813 (β [se] = -0.26[0.10] kg/m²; P = 1.12 × 10-2), 
248bp from the most significant association observed in TwinsUK (rs3751812), while 
the AMY1 association was P = 5.38 x 10
-6
 (β [se] = -0.64[0.14]) (Supplementary 
Table 15). The FTO SNP rs1558902 showed the most significant association with 
BMI variation in the largest GIANT meta-analysis
5
. In Twins UK and DESIR, SNP 
rs1558902 was significantly associated with increased BMI (β [se]= 0.39 [0.19] kg/m² 
and P = 3.47 × 10
-2
; and β [se]= 0.25 [0.10] kg/m², P = 1.56 × 10-2; respectively) 
while AMY1 estimated copy-number association showed a much stronger level of 
significance and effect (β [se] = -0.86 [0.25] kg/m²; P = 5.52 × 10-4; and β [se] = -0.64 
[0.14] kg/m²; P = 5.38 × 10
-6
; respectively; Supplementary Tables 14-15).  
 
3.12. qPCR-estimated copy-number association analysis in AOB 
Association analysis was carried out between cases and controls using a generalized 
mixed effects model including age and sex as covariates and genotyping plate as a 
random effect. Furthermore, association between carriers of low and high copy-
numbers was also carried out using a binary variable to categorize subjects below and 
above the first (≤3 copy-numbers) and last (≥10 copy-numbers) decile of the 
estimated copy-number distribution, respectively.  
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To assess if any spurious association was resulting from rounding of the calculated 
copy-number to the closest integer value, we carried out associations with both the 
residuals (integer copy-number value – calculated copy-number value) and its 
absolute value against obesity. Association was not significant (P = 0.31; Pabsolute = 
0.62). 
3.13. Meta-analyses 
Meta-analyses for both BMI and obesity were performed using the software program 
METAL (www.sph.umich.edu/csg/abecasis/metal) which performs an inverse-
variance method of meta-analysis with fixed effects, by combining effect sizes and 
weighting them by their standard errors (Table 1 and Supplementary Tables 10-11). 
 
3.14. Estimation of the proportion of genetic variance for BMI and obesity 
explained by copy-number variation in AMY1 
We assessed the proportion of genetic variance for BMI explained by inferred copy-
numbers at AMY1. We calculated correlation coefficients r between inferred copy-
numbers and BMI, adjusted for age, sex (DESIR), qPCR plate, and family (TwinsUK) 
and transformed into Fisher z-scores: 
z = (0.5)ln
1+ r
1- r  
with derivation of their standard error as: 
SEz =
1
n-3  
where n is the number of samples in each study. 
z-scores were combined using the inverse variance method, with the function metagen 
of the package meta in R. Combined z-score and its 95% confidence interval were 
then back-transformed to r values : 
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r =
e2z -1
e2z +1
 
and squared to assess the BMI variance explained by variation in inferred copy-
numbers at the AMY1 gene. 
Correlations in DESIR (n=2,137) and TwinsUK (n=1,479) were r=0.085 and r=0.111, 
respectively. Combined correlation was 0.1001 [95% CI = 0.0682; 0.1327; P < 1.00 x 
10
-4
; Heterogeneity P = 0.45]. 
Assuming heritability for BMI between 40-70% the variance explained by inferred 
copy-numbers at AMY1 lies between 0.66% and 4.40%. 
 
The proportion of genetic variance for obesity explained (Vg) by inferred AMY1 
copy-numbers was estimated according to So et al
24
 using applied by post-hoc 
binning of our case-control samples into low, intermediate and high categories of 
AMY1 estimated copy-number. The population frequencies of copy-numbers were 
based on a weighted average of the frequencies in cases and controls, the weight 
being the prevalence of obese and non-obese in the population. Amylase effect on 
obesity between carriers of high estimated copy-numbers (greater than 7; 25% of each 
sample) and either carriers of the most common estimated copy-numbers of (between 
5 and 7 representing 50% of each case control samples), and carriers of low estimated 
copy-numbers (less than 5; 25% of each sample) are reported in Supplementary 
Table 11. Prevalence of obesity was taken to be 16.85%
25
. The 95% confidence 
interval was estimated by a simulation approach, assuming a normal distribution of 
ln(OR) with SE as obtained from the generalized linear mixed model. Random normal 
variables were generated and the corresponding Vg calculated.  
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3.15. Analyses between qPCR-estimated copy-number, serum protein levels and 
BMI in ABOS  
The relationship between copy-number at AMY1 and AMY2 inferred by qPCR and the 
salivary and pancreatic amylase levels measured in serum for 468 patients was 
assessed using multiple regression models with qPCR-typed copy-number at both 
AMY1 and AMY2 genes as predictors. The relationship between salivary and 
pancreatic amylase levels and BMI was assessed using multiple regression models 
with the protein levels as predictors. Age and sex were used as covariates. No 
significance gender differences between males and females were observed in either 
salivary (P = 0.13) or pancreatic amylase (P = 0.39) mean levels, nor estimated 
between copy-numbers at AMY1 (P = 0.94) or AMY2 (P = 0.54).  
AMY1 copy-number distribution in obese subjects of the ABOS cohort was identical 
to the one observed in the AOB obese cases (Wilcoxon P = 0.98), however we did not 
include the ABOS sample in the case-control association as copy-number estimates in 
this sample were generated in a separate experiment. 
 
 
3.16. AMY1 expression levels in adipose tissue 
Despite several historical reports of amylase enzyme activity in a number of different 
tissue types other than the salivary glands, including adipose tissue, its transcriptional 
levels in such tissues have not been well documented. In our Swedish family sample, 
amylase transcript levels (probeset 208498_s_at) in subcutaneous adipose tissue were 
ranked among the top 11% most-expressed transcripts. 
To validate these results, we examined an independent, publicly-available gene 
expression dataset derived from subcutaneous adipose tissue of 856 subjects, 
generated using a different microarray platform and deposited in ArrayExpress 
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(experiment E-TABM-1140). Data were available for 48,638 probes measured on the 
IlluminaHT12 v3.0 array, including three probesets with high specificity for AMY1 
(ILMN_2294762, ILMN_1726327 and ILMN_1663313). These data confirmed 
strong expression of AMY1 in adipose tissue, with the three probes ranked in the top 
23%, 27% and 3% most-expressed genes (average across all three probesets ranked 
within top 13%).  
3.17. Copy number measurement outlier analyses 
In our study, we took particular care to design our experiments so as to ensure even 
BMI distribution across plates for copy number estimation, in order to avoid false 
positive associations that may arise through batch effects. However, we did observe 
some differences across plates in the AMY1 copy number distribution, which are 
likely to be a consequence of the limitations in the available technologies for copy 
number estimation at such multi-allelic loci in large experiments. 
Therefore, we conducted a multiple comparison test after Kruskal-Wallis using the 
function kruskal (R package Agricolae) in order to identify potential “outlier” plates 
in DESIR and TwinsUK, to exclude the possibility of a false-positive association 
driven by potential batch effects. By removing 13 plates (n = 587 subjects) from 
DESIR (Kruskal-Wallis P < 0.05) the association with BMI remained significant with 
β [se] -0.17[0.03]; P = 5.14×10-7.  Analogously, by removing 12 plates (n = 444 
subjects) from TwinsUK (Kruskal-Wallis P < 0.05) the association with BMI 
remained significant with β [se] -0.17[0.06]; P = 5.85×10-3. 
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